1178830-06-2 Usage
Uses
Used in Pharmaceutical Research:
(4-bromo-2-fluorophenyl)methanesulfonyl chloride is used as a reagent for introducing sulfonyl chloride functional groups into various organic molecules. This application is crucial in the development of new pharmaceuticals, as these functional groups can enhance the biological activity and pharmacokinetic properties of the resulting compounds.
Used in Agrochemical Synthesis:
In the agrochemical industry, (4-bromo-2-fluorophenyl)methanesulfonyl chloride is used as an intermediate for the synthesis of sulfonylurea herbicides. These herbicides are essential for modern agriculture, as they provide effective and selective weed control, leading to increased crop yields and reduced labor requirements.
Used in Organic Synthesis:
(4-bromo-2-fluorophenyl)methanesulfonyl chloride is also utilized in the broader field of organic synthesis, where it serves as a versatile intermediate for the preparation of various organic compounds. Its high reactivity allows it to participate in a range of chemical reactions, including nucleophilic substitution, which is a fundamental reaction type in organic chemistry.
Overall, (4-bromo-2-fluorophenyl)methanesulfonyl chloride is a multifaceted compound with significant applications across the pharmaceutical, agrochemical, and broader organic synthesis industries. Its unique properties and reactivity make it an indispensable tool in the development of new and improved chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1178830-06-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,8,8,3 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1178830-06:
(9*1)+(8*1)+(7*7)+(6*8)+(5*8)+(4*3)+(3*0)+(2*0)+(1*6)=172
172 % 10 = 2
So 1178830-06-2 is a valid CAS Registry Number.
1178830-06-2Relevant articles and documents
Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
-
, (2008/06/13)
The invention concerns novel compound of general formula (1) in which: P, T1, T2, X and n are as defined in claim 1, their tautomeric forms, and their additive salts with pharmaceutically acceptable bases. The invention also concerns methods for preparing these compounds and their applications as medicines. These compounds inhibit the aldose reductase enzyme and can be used in the treatment or prevention of peripheral and autonomous neurological diabetic complications, renal and ocular disorders such as cataract and retinopathy.
